Shannon Chuai

5.3k total citations
37 papers, 1.5k citations indexed

About

Shannon Chuai is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Shannon Chuai has authored 37 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 21 papers in Cancer Research and 14 papers in Oncology. Recurrent topics in Shannon Chuai's work include Cancer Genomics and Diagnostics (20 papers), Lung Cancer Treatments and Mutations (20 papers) and Urinary Bladder and Prostate Research (6 papers). Shannon Chuai is often cited by papers focused on Cancer Genomics and Diagnostics (20 papers), Lung Cancer Treatments and Mutations (20 papers) and Urinary Bladder and Prostate Research (6 papers). Shannon Chuai collaborates with scholars based in China, United States and Canada. Shannon Chuai's co-authors include Marc Ladanyi, Adam B. Olshen, Zhou Zhang, J. Richard Landis, Mark S. Litwin, J. Curtis Nickel, John W. Kusek, Mary McNaughton‐Collins, Anthony J. Schaeffer and Michel A. Pontari and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Shannon Chuai

36 papers receiving 1.4k citations

Peers

Shannon Chuai

PRM

ONCOL

UROLO

Renato Colella Italy

Shimiao Zhu China

Emanuela Matteucci Italy

Danilo Zani Italy

Hideaki Kakinuma Japan

Łukasz Szylberg Poland

Masato Kitazawa Japan

Carol Wong Hong Kong

Cristiana Simionescu Romania

Yukihiro Endo Japan

Renato Colella Italy

Shannon Chuai

285 ×0.4

PRM

261 ×0.5

ONCOL

128 ×0.3

185 ×0.6

33 ×0.1

UROLO

Citations per year, relative to Shannon Chuai Shannon Chuai (= 1×) peers Renato Colella

Countries citing papers authored by Shannon Chuai

Since Specialization

Citations

This map shows the geographic impact of Shannon Chuai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shannon Chuai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shannon Chuai more than expected).

Fields of papers citing papers by Shannon Chuai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shannon Chuai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shannon Chuai. The network helps show where Shannon Chuai may publish in the future.

Co-authorship network of co-authors of Shannon Chuai

This figure shows the co-authorship network connecting the top 25 collaborators of Shannon Chuai. A scholar is included among the top collaborators of Shannon Chuai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shannon Chuai. Shannon Chuai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fan, Yun, Yang Liu, Yiran Cai, et al.. (2023). bITH, a blood-based metric of intratumor heterogeneity, is associated with clinical response to immune checkpoint blockade in non-small cell lung cancer. EBioMedicine. 91. 104564–104564. 3 indexed citations

Chen, Kezhong, Fan Yang, Olga Chervova, et al.. (2023). Individualized tumor-informed circulating tumor DNA analysis for postoperative monitoring of non-small cell lung cancer. Cancer Cell. 41(10). 1749–1762.e6. 54 indexed citations

Yao, Qianlan, Yanhui Liu, Qianming Bai, et al.. (2022). Mutation Landscape of Homologous Recombination Repair Genes in Epithelial Ovarian Cancer in China and Its Relationship With Clinicopathlological Characteristics. Frontiers in Oncology. 12. 709645–709645. 5 indexed citations

Zhang, Bin, Lianmin Zhang, Dongsheng Yue, et al.. (2020). Genomic characteristics in Chinese non-small cell lung cancer patients and its value in prediction of postoperative prognosis. Translational Lung Cancer Research. 9(4). 1187–1201. 12 indexed citations

Wang, Ye, Yanqi He, Panwen Tian, et al.. (2020). Low T790M relative allele frequency indicates concurrent resistance mechanisms and poor responsiveness to osimertinib. Translational Lung Cancer Research. 9(5). 1952–1962. 11 indexed citations

Kang, Guannan, Kezhong Chen, Fan Yang, et al.. (2019). Monitoring of circulating tumor DNA and its aberrant methylation in the surveillance of surgical lung Cancer patients: protocol for a prospective observational study. BMC Cancer. 19(1). 579–579. 25 indexed citations

Zheng, Mei-Mei, Yang-Si Li, Ben‐Yuan Jiang, et al.. (2019). Clinical Utility of Cerebrospinal Fluid Cell-Free DNA as Liquid Biopsy for Leptomeningeal Metastases in ALK-Rearranged NSCLC. Journal of Thoracic Oncology. 14(5). 924–932. 75 indexed citations

Xia, Shu, Junyi Ye, Yu Chen, et al.. (2019). Parallel serial assessment of somatic mutation and methylation profile from circulating tumor DNA predicts treatment response and impending disease progression in osimertinib-treated lung adenocarcinoma patients. Translational Lung Cancer Research. 8(6). 1016–1028. 16 indexed citations

Zhou, Qing, Yujie Zhang, Zhenhua Chen, et al.. (2018). MA15.06 Circulating Tumor DNA Portrays the Resistance Landscape to a Novel Third Generation EGFR Inhibitor, AC0010. Journal of Thoracic Oncology. 13(10). S408–S409. 1 indexed citations

10.

Li, Yan, Tongtong Zhang, Jing Zhang, et al.. (2018). Response to crizotinib in advanced ALK -rearranged non-small cell lung cancers with different ALK -fusion variants. Lung Cancer. 118. 128–133. 44 indexed citations

11.

Han, Jiefei, Qiuyi Zhang, Qing Zhou, et al.. (2017). P3.02b-116 Molecular Mechanism of Transformation from Adenocarcinoma to Small-Cell Lung Cancer after EGFR-TKI. Journal of Thoracic Oncology. 12(1). S1263–S1264. 1 indexed citations

12.

Han, Jiefei, Qiuyi Zhang, Qing Zhou, et al.. (2017). JCES01.24 Molecular Mechanism of Transformation from Adenocarcinoma to Small-Cell Lung Cancer after EGFR-TKI. Journal of Thoracic Oncology. 12(1). S240–S241. 1 indexed citations

13.

Li, Wenbin, Jing Zhang, Lei Guo, et al.. (2016). Combinational Analysis of FISH and Immunohistochemistry Reveals Rare Genomic Events in ALK Fusion Patterns in NSCLC that Responds to Crizotinib Treatment. Journal of Thoracic Oncology. 12(1). 94–101. 42 indexed citations

14.

Chuai, Shannon, et al.. (2016). Non-invasive detection of response and crizotinib induced resistance in ROS1 fusion advanced stage Chinese lung adenocarcinoma patients using next-generation genotyping from cfDNA. Annals of Oncology. 27. vi438–vi438.

15.

Mao, Xiaowei, Zhou Zhang, Xiaoxuan Zheng, et al.. (2016). Capture-Based Targeted Ultradeep Sequencing in Paired Tissue and Plasma Samples Demonstrates Differential Subclonal ctDNA-Releasing Capability in Advanced Lung Cancer. Journal of Thoracic Oncology. 12(4). 663–672. 99 indexed citations

16.

Chuai, Shannon, et al.. (2011). Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype. Oncogene. 31(6). 671–682. 107 indexed citations

17.

Fu, Shijun, Qi Fei, Hua Jiang, et al.. (2011). Involvement of Histone Acetylation of Sox17 and Foxa2 Promoters during Mouse Definitive Endoderm Differentiation Revealed by MicroRNA Profiling. PLoS ONE. 6(11). e27965–e27965. 21 indexed citations

18.

Nickel, J. Curtis, John N. Krieger, Mary McNaughton‐Collins, et al.. (2008). Alfuzosin and Symptoms of Chronic Prostatitis–Chronic Pelvic Pain Syndrome. New England Journal of Medicine. 359(25). 2663–2673. 135 indexed citations

19.

Laé, Marick, et al.. (2007). Global gene expression profiling of PAX‐FKHR fusion‐positive alveolar and PAX‐FKHR fusion‐negative embryonal rhabdomyosarcomas. The Journal of Pathology. 212(2). 143–151. 95 indexed citations

20.

López‐Ríos, Fernando, Shannon Chuai, Raja M. Flores, et al.. (2006). Global Gene Expression Profiling of Pleural Mesotheliomas: Overexpression of Aurora Kinases and P16/CDKN2A Deletion as Prognostic Factors and Critical Evaluation of Microarray-Based Prognostic Prediction. Cancer Research. 66(6). 2970–2979. 193 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact